Summary of Study ST003480
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002137. The data can be accessed directly via it's Project DOI: 10.21228/M8CZ33 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST003480 |
Study Title | Fatty acid analysis of human colorectal adenocarcinoma tumors of normal weight (BMI<25) and obese (BMI>30) patients revealed an increase in oleic acid in obese patients. |
Study Summary | Frozen human colorectal adenocarcinoma tumors samples were acquired and analyzed for fatty acid composition via GC-FID. These data revealed an increase in several fatty acids, such as palmitic acid, stearic acid, oleic acid, etc., in obese patients. However, oleic acid was the most abundant fatty acid in tumors of obese patients and also the fatty acid that exhibited the most significant increase in obese patients compared to normal-weight patients. |
Institute | Stanford University |
Last Name | Bagchi |
First Name | Sreya |
Address | 3373 Hill Avenue, Palo Alto, CA, 94304, USA |
bagchipuja@gmail.com | |
Phone | 4086214773 |
Submit Date | 2024-08-12 |
Analysis Type Detail | Other |
Release Date | 2024-10-18 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR002137 |
Project DOI: | doi: 10.21228/M8CZ33 |
Project Title: | Acid-sensing receptor, GPR65, on tumor macrophages drives accelerated tumor growth in obesity |
Project Summary: | Multiple cancers, including colorectal cancer (CRC), are more frequent and often more aggressive in obese individuals. Here, we show that macrophages accumulate within tumors of obese CRC patients and in obese CRC mice and promote accelerated tumor growth. These changes are initiated by oleic acid accumulation and subsequent tumor cell-derived acid production, and driven by signaling through GPR65, an acid-sensing receptor on CRC-associated macrophages. We demonstrate a similar role for GPR65 in hepatocellular carcinoma (HCC) in obese mice. Tumors in obese patients with CRC or HCC also exhibit increased GPR65 expression, suggesting that the mechanism revealed here likely contributes to tumor growth in a range of obesity-associated cancers and represents a potential therapeutic target. |
Institute: | Stanford University |
Last Name: | Bagchi |
First Name: | Sreya |
Address: | 3373 Hillview Avenue |
Email: | sbagchi@stanford.edu |
Phone: | 4086214773 |
Subject:
Subject ID: | SU003608 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Sample source | Group |
---|---|---|---|
SA383752 | Sample 10 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383753 | Sample 2 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383754 | Sample 14 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383755 | Sample 13 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383756 | Sample 12 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383757 | Sample 11 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383758 | Sample 1 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383759 | Sample 9 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383760 | Sample 7 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383761 | Sample 6 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383762 | Sample 5 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383763 | Sample 4 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383764 | Sample 3 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383765 | Sample 8 - Normal | Colorectal adenocarcinoma tumor | Non-obese |
SA383766 | Sample 24 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383767 | Sample 29 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383768 | Sample 28 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383769 | Sample 27 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383770 | Sample 26 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383771 | Sample 25 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383772 | Sample 20 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383773 | Sample 23 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383774 | Sample 22 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383775 | Sample 21 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383776 | Sample 19 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383777 | Sample 18 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383778 | Sample 17 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383779 | Sample 15 - Obese | Colorectal adenocarcinoma tumor | Obese |
SA383780 | Sample 16 - Obese | Colorectal adenocarcinoma tumor | Obese |
Showing results 1 to 29 of 29 |
Collection:
Collection ID: | CO003601 |
Collection Summary: | CRC tumor sample from patients were collected and frozen by the Stanford tissue bank. Samples were collected from non-obese and obese patients. |
Sample Type: | Colorectal adenocarcinoma tumors |
Treatment:
Treatment ID: | TR003617 |
Treatment Summary: | Patients were treatment naive. |
Sample Preparation:
Sampleprep ID: | SP003615 |
Sampleprep Summary: | Tumors were surgically removed and frozen until further use. |
Sampleprep Protocol ID: | CRC_fatty_acid_protocol.pdf |
Combined analysis:
Analysis ID | AN005715 |
---|---|
Analysis type | MS |
Chromatography type | GC |
Chromatography system | Agilent 6890N |
Column | Agilent DB-23 (60m x 0.25mm x 0.25um) |
MS Type | Other |
MS instrument type | Other |
MS instrument name | N/A (FID detection was used) |
Ion Mode | UNSPECIFIED |
Units | nmol/mg dry wt |
Chromatography:
Chromatography ID: | CH004336 |
Chromatography Summary: | GC-FID was performed on an Agilent 6890N GC coupled to a FID ( flame ionization detector). The FID detector was operated at 260 °C. The hydrogen flow to the detector was 30 mL/min and air flow was 400 mL/min. The sampling rate of the FID was 20 Hz. |
Methods Filename: | CRC_fatty_acid_protocol.pdf |
Instrument Name: | Agilent 6890N |
Column Name: | Agilent DB-23 (60m x 0.25mm x 0.25um) |
Column Temperature: | 250 |
Flow Gradient: | Temperature-programmed GC |
Flow Rate: | 1.5 mL/min |
Internal Standard: | pentadecanoic acid (15:0) |
Solvent A: | 3 M methanolic hydrochloric acid |
Solvent B: | 100% hexane |
Chromatography Type: | GC |
MS:
MS ID: | MS005438 |
Analysis ID: | AN005715 |
Instrument Name: | N/A (FID detection was used) |
Instrument Type: | Other |
MS Type: | Other |
MS Comments: | No MS involved (FID detection was used) |
Ion Mode: | UNSPECIFIED |